{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:05:58Z","timestamp":1778526358089,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["J16K10705"],"award-info":[{"award-number":["J16K10705"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1245\/s10434-020-08228-9","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T22:10:56Z","timestamp":1580249456000},"page":"2438-2447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["High Neutrophil Count as a Negative Prognostic Factor for Relapse in Patients with Thymic Epithelial Tumor"],"prefix":"10.1245","volume":"27","author":[{"given":"Satoru","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tsunezuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ikebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"8228_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","volume":"44","author":"WK de Jong","year":"2008","unstructured":"de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ. Thymic epithelial tumors: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer. 2008; 44:123\u201330.","journal-title":"Eur J Cancer"},{"key":"8228_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/JTO.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx A, Chan JK, Coindre JM, et al. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015; 10:1383\u201395.","journal-title":"J Thorac Oncol"},{"key":"8228_CR3","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","volume":"9","author":"FC Detterbeck","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D, et al. The IASLC\/ITMIG thymic epithelial tumors staging project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014; 9:S65\u201372.","journal-title":"J Thorac Oncol"},{"key":"8228_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ejcts\/ezv389","volume":"49","author":"T Fukui","year":"2016","unstructured":"Fukui T, Fukumoto K, Okasaka T, et al. Clinical evaluation of a new tumor-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group. Eur J Cardiothorac Surg. 2016; 49:574\u20139.","journal-title":"Eur J Cardiothorac Surg"},{"key":"8228_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/ejcts\/ezz001","volume":"56","author":"M Okumura","year":"2019","unstructured":"Okumura M, Yoshino I, Yano M, et al. Tumor size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma. Eur J Cardiothorac Surg. 2019; 56:174\u201381.","journal-title":"Eur J Cardiothorac Surg"},{"key":"8228_CR6","doi-asserted-by":"publisher","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","volume":"6","author":"F Detterbeck","year":"2011","unstructured":"Detterbeck F, Youssef S, Ruffini E, Okumura M. A review of prognostic factors in thymic malignancies. J Thorac Oncol. 2011; 6:S1698\u2013S1704.","journal-title":"J Thorac Oncol"},{"key":"8228_CR7","doi-asserted-by":"publisher","first-page":"S1324","DOI":"10.1245\/s10434-015-4735-5","volume":"22","author":"Y Takahashi","year":"2015","unstructured":"Takahashi Y, Horio H, Hato T, et al. Prognostic significance of preoperative neutrophil-lymphocyte ratios in patients with stage I non-small cell lung cancer after complete resection. Ann Surg Oncol. 2015; 22:S1324\u201331.","journal-title":"Ann Surg Oncol"},{"key":"8228_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106:dju124.","journal-title":"J Natl Cancer Inst"},{"key":"8228_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12307-014-0147-5","volume":"8","author":"RV Sionov","year":"2015","unstructured":"Sionov RV, Fridlender ZG, Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2015; 8:125\u201358.","journal-title":"Cancer Microenviron"},{"key":"8228_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-017-0707-7","volume":"16","author":"A Ocana","year":"2017","unstructured":"Ocana A, Nieto-Jimenez C, Pandiella A, Templeton AJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017; 16:137.","journal-title":"Mol Cancer"},{"key":"8228_CR11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.athoracsur.2008.04.070","volume":"86","author":"J Nakajima","year":"2008","unstructured":"Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg. 2008;86:941\u201345.","journal-title":"Ann Thorac Surg"},{"key":"8228_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.athoracsur.2014.10.068","volume":"99","author":"Y Yamada","year":"2015","unstructured":"Yamada Y, Yoshida S, Iwata T, et al. Risk factors for developing postthymectomy myasthenia gravis in thymoma patients. Ann Thorac Surg. 2015; 99:1013\u201319.","journal-title":"Ann Thorac Surg"},{"key":"8228_CR13","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1309\/AJCP76KEGWQKWOKA","volume":"137","author":"CA Moran","year":"2012","unstructured":"Moran CA, Weissferdt A, Kalhor N, et al. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol. 2012; 137:444\u201350.","journal-title":"Am J Clin Pathol"},{"key":"8228_CR14","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","volume":"22","author":"P Strobel","year":"2004","unstructured":"Strobel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol. 2004; 22:1501\u201309.","journal-title":"J Clin Oncol"},{"key":"8228_CR15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00595-017-1602-y","volume":"48","author":"M Yanagiya","year":"2018","unstructured":"Yanagiya M, Nitadori JI, Nagayama K, Anraku M, Sato M, Nakajima J. Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma. Surg Today. 2018; 48:422\u201330.","journal-title":"Surg Today"},{"key":"8228_CR16","doi-asserted-by":"publisher","first-page":"21861","DOI":"10.18632\/oncotarget.25076","volume":"9","author":"S Janik","year":"2018","unstructured":"Janik S, Raunegger T, Hacker P, et al. Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome. Oncotarget. 2018; 9:21861\u201375.","journal-title":"Oncotarget"},{"key":"8228_CR17","doi-asserted-by":"publisher","first-page":"47090","DOI":"10.18632\/oncotarget.17478","volume":"8","author":"S Janik","year":"2017","unstructured":"Janik S, Bekos C, Hacker P, et al. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: a pro- and retrospective analysis. Oncotarget. 2017; 8:47090\u2013102.","journal-title":"Oncotarget"},{"key":"8228_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.21037\/jtd.2016.05.05","volume":"8","author":"ZY Yuan","year":"2016","unstructured":"Yuan ZY, Gao SG, Mu JW, et al. Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma. J Thorac Dis. 2016; 8:1487\u201396.","journal-title":"J Thorac Dis"},{"key":"8228_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13019-018-0805-7","volume":"13","author":"P Muriana","year":"2018","unstructured":"Muriana P, Carretta A, Ciriaco P, Bandiera A, Negri G. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma. J Cardiothorac Surg. 2018; 13:119.","journal-title":"J Cardiothorac Surg"},{"key":"8228_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","volume":"132","author":"A Meager","year":"2003","unstructured":"Meager A, Wadhwa M, Dilger P, et al. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis. Clin Exp Immunol. 2003; 132:128\u201336.","journal-title":"Clin Exp Immunol"},{"key":"8228_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fphys.2018.00113","volume":"9","author":"C Rosales","year":"2018","unstructured":"Rosales C. Neutrophil: a cell with many roles in inflammation or several cell types? Front Physiol. 2018; 9:113.","journal-title":"Front Physiol"},{"key":"8228_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","volume":"20","author":"Z Granot","year":"2011","unstructured":"Granot Z, Henke E, Comen EA, et al. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011; 20:300\u201314.","journal-title":"Cancer Cell"},{"key":"8228_CR23","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/j.1349-7006.2008.00897.x","volume":"99","author":"K Inai","year":"2008","unstructured":"Inai K, Takagi K, Takimoto N, et al. Multiple inflammatory cytokine-productive ThyL-6 cell line established from a patient with thymic carcinoma. Cancer Sci. 2008; 99:1778\u201384.","journal-title":"Cancer Sci"},{"key":"8228_CR24","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1016\/j.ejca.2009.01.023","volume":"45","author":"S Teramukai","year":"2009","unstructured":"Teramukai S, Kitano T, Kishida Y, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer. 2009; 45:1950\u201358.","journal-title":"Eur J Cancer"},{"key":"8228_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/ejcts\/ezv086","volume":"49","author":"G Marulli","year":"2016","unstructured":"Marulli G, Margaritora S, Lucchi M, et al. Surgical treatment of recurrent thymoma: is it worthwhile? Eur J Cardiothorac Surg. 2016; 49:327\u201332.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08228-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:18:33Z","timestamp":1611706713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["8228"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08228-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Satoru Okada, Masanori Shimomura, Hiroaki Tsunezuka, Shunta Ishihara, Satoshi Ikebe, Tatsuo Furuya, Junichi Shimada, Satoshi Teramukai, and Masayoshi Inoue declare there are no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}